One ablation electrode. Multiple solutions.
The future of radiofrequency ablation needle technology begins with the VIVA II. Our monopolar needle electrode configuration with an adjustable active tip is the first of its kind in the United States. Discover the features that set this next-generation tool apart.The VIVA II monopolar electrode has been pioneered for versatility with its adjustable active tip to achieve large central ablations as well as smaller, precise peripheral ablations. It includes six active tip lengths, with the ability to safely toggle mid-procedure for seamless application.
The versatile VIVA II enables adjustable ablation, targeting multiple lesions of different sizes in one session with one RFA electrode. More efficient treatment leads to increased patient satisfaction and more positive outcomes.
Achieve next-level precision with our STARmed RF System that has been utilized in over 80% of clinical articles referencing radiofrequency ablation (RFA) for thyroid nodules. We take pride in the high-quality clinical evidence gathered through global collaborative research initiatives.
STARmed dedicated years of research to sharpen up its ablation electrode tips. Experience smoother skin punctures and effortless lesion access with VIVA II’s latest sharp technology. Clinicians consistently complete treatment without the need for an incision, making it one of the least invasive monopolar needle electrodes on the market.
The VIVA II monopolar RFA needle electrode features 6 active tip lengths from 5mm to 30mm in 5 mm increments, eliminating the need to stock multiple electrode sizes.
The lighter and smaller handle promotes a comfortable grip for better precision control. The upgraded tubing system simplifies organization and procedure management. We also collaborated with clinicians to develop the most stable pump system available. The result was a reduction in vibrations, enhancing physician control and ensuring the most precise treatment possible.
Yes. The VIVA II monopolar electrode is the first radiofrequency ablation needle with an adjustable active tip technology cleared for use in the United States. This FDA clearance ensures the device meets strict safety and efficacy standards for clinical practice.
Yes. Monopolar needle electrodes such as the VIVA II are designed for safe, repeated use in clinical ablation procedures when utilized according to their IFU. The adjustable ablation electrode design also minimizes the need for multiple devices, reducing patient risk and improving procedural efficiency.
